A 73-Year-Old Man with Advanced Renal Cell Carcinoma - Episode 2

Efficacy and Quality of Life Data from 5-Year Follow-Up of CheckMate 214

Dr Rana McKay discusses the efficacy and qualify-of-life data from the 5-year follow-up of the CheckMate 214 trial investigating nivolumab plus ipilimumab in frontline advanced renal cell carcinoma treatment.